Medication-info.com Search Menu

Kyxata (Carboplatin): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning Current since November 16, 2026
Strength:
20 mg/2 mL, 80 mg/8 mL, 500 mg/50 mL
Drug class:
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Kyxata

What is the most important information I should know about KYXATA?

KYXATA can cause allergic reactions, including serious allergic reactions that can be life-threatening. KYXATA is a platinum-based medicine. Serious allergic reactions can happen in people who take KYXATA and who have had a previous allergic reaction to platinum-based medicines. Serious allergic reactions can happen within a few minutes of your KYXATA infusion or any time during your treatment with KYXATA.

Tell your healthcare provider or get emergency medical help right away if you:

  • have trouble breathing
  • feel like your throat is closing up

Call your healthcare provider right away if you get any of the following signs or symptoms of an allergic reaction:

  • rash
  • flushed face
  • hives
  • itching
  • swelling of your lips or tongue
  • sudden cough
  • dizziness or feel faint
  • sweating
  • chest pain

See "What are the possible side effects of KYXATA?" for more information about side effects.

What is KYXATA?

KYXATA is a prescription medicine used to treat adults:

  • in combination with another chemotherapy medicine, for your first treatment of advanced ovarian cancer.
  • alone when your ovarian cancer has come back (recurrent) after you have been treated with prior chemotherapy medicines.

It is not known if KYXATA is safe and effective in children.

Before you receive KYXATA tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney problems
  • are pregnant or plan to become pregnant. KYXATA can harm your unborn baby.

Females who are able to become pregnant:

○ Your healthcare provider will check to see if you are pregnant before you start treatment with KYXATA.

○ Use effective birth control (contraception) during treatment with KYXATA and for 6 months after your last dose.

○ Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with KYXATA.

Males with female partners who are able to become pregnant:

○ Use effective birth control (contraception) during treatment with KYXATA and for 3 months after your last dose.

○ Tell your healthcare provider right away if your female partner becomes pregnant or thinks she may be pregnant during your treatment with KYXATA.

  • are breastfeeding or plan to breastfeed. It is not known if KYXATA passes into your breast milk. Do not breastfeed during treatment with KYXATA and for 1 week after your last dose of KYXATA. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take , including prescription and over‑the‑counter medicines, vitamins, and herbal supplements.

How will I receive KYXATA?

  • Your healthcare provider will give you KYXATA into your vein as an intravenous (IV) infusion over 30 to 60 minutes.
  • Your healthcare provider will give you medicines before each KYXATA infusion to help prevent nausea and vomiting and may continue these medicines after your infusion as needed.
  • For advanced ovarian cancer, KYXATA may be given in combination with another chemotherapy medicine on Day 1 of each cycle. Your healthcare provider will decide how often KYXATA is given based on the other chemotherapy medicine used with KYXATA.
  • For recurrent ovarian cancer, KYXATA may be given alone on Day 1 every 4 weeks (1 cycle).
  • Your healthcare provider will decide how many treatments you need.
  • Your healthcare provider may change your dose of KYXATA, or tell you to stop KYXATA for a short period of time or permanently if you have certain side effects.

What are the possible side effects of KYXATA?

KYXATA can cause serious side effects, including:

See "What is the most important information about KYXATA?" above.

  • Low blood cell counts . Decreased red blood cells, white blood cells, and platelets are common with KYXATA, but can also be severe and lead to bleeding or infections that can cause death. Some people have needed blood transfusions. Your healthcare provider will do blood tests before you start and during treatment with KYXATA to check your blood cell counts. Tell your healthcare provider right away if you develop a fever of 100.5°F or greater or get any of the following signs or symptoms:

○ chills or shivering

○ cough

○ pain

○ burning or pain on urination

○ feeling tired

○ shortness of breath

○ unusual bruising or bleeding

○ black tarry stools

○ blood in your urine

  • Nausea and vomiting. Nausea and vomiting are common during treatment with KYXATA but can also be severe. Before each infusion of KYXATA, you will receive medicines to help prevent nausea and vomiting. You may receive medicines after your infusion if needed. Tell your healthcare provider right away if you have severe nausea or vomiting that does not stop.
  • Peripheral neuropathy. Tell your healthcare provider if you develop tingling, numbness, or burning (feel like "pins and needles") in your hands or feet.

The most common side effects in adults with advanced ovarian cancer who received KYXATA in combination with another chemotherapy medicine include:

  • decreased white blood cells
  • nausea and vomiting
  • decreased red blood cells (anemia)
  • decreased platelets
  • decreased magnesium
  • diarrhea
  • constipation
  • hair loss
  • weakness
  • pain

The most common side effects in adults with recurrent ovarian cancer who received KYXATA alone include:

  • nausea and vomiting
  • decreased red blood cells (anemia)
  • decreased white blood cells
  • decreased platelets
  • decreased sodium
  • decreased magnesium
  • increased alkaline phosphatase
  • decreased calcium

These are not all the possible side effects of KYXATA.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of KYXATA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for more information about KYXATA that is written for health professionals.

What are the ingredients in KYXATA?

Active ingredient: carboplatin

Manufactured for:

AVYXA Pharma, LLC

New Jersey 07054, USA

Made in Switzerland

For more information, call 1-888-520-0954.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 219921 · View the label on DailyMed

Revision date stated in the text: November 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Kyxata

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Platinum-based Drug
Active ingredient Carboplatin
Dosage form Injection
Route Intravenous
Marketing status listed in the FDA NDC Directory
Company (applicant) AVYXA HOLDINGS
FDA approval NDA 219921New Drug Application (NDA) Approved August 8, 2025
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Drug shortage
  • Current since November 16, 2026
Packages (NDC)
Package
20 mg/2 mL – 2 ml in 1 vial, multi-dose / 1 in 1 carton NDC 83831-140-02
80 mg/8 mL – 8 ml in 1 vial, multi-dose / 1 in 1 carton NDC 83831-141-08
500 mg/50 mL – 50 ml in 1 vial, multi-dose / 1 in 1 carton NDC 83831-142-50

Source: FDA drug labeling via NLM DailyMed, data as of November 19, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.